Document Detail


Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens.
MedLine Citation:
PMID:  2227068     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The ethinylestradiol-norgestrel combination (EE-NG) for postcoital contraception, as described by Yuzpe, has been shown to be an effective method but with frequent side effects. To overcome the problem of adverse effects a new approach using danazol was proposed, but the efficacy and acceptability of this treatment have not yet been tested in large studies. In a 5-year period at the AIECS Family Planning Centre in Milan we treated 2448 women requesting postcoital contraception using Yuzpe's regimen and two danazol regimens (800 mg/1200 mg). The patients' acceptability for danazol treatment was higher than for Yuzpe's regimen due to fewer, milder and shorter side effects. Nine pregnancies occurred in the EE-NG group (2.21%), 17 in the 800 mg group (1.71%) and 6 in the 1200 mg group (0.82%). Our study shows a statistically significant efficacy against expected pregnancy rates both with Yuzpe's regimen and with danazol. The 1200 mg danazol treatment seems to be more effective and can be considered a valid alternative to the EE-NG combination for hormonal postcoital contraception.
The ethinyl estradiol-norgestrel combination (EE-NG) for postcoital contraception as described by Yuzpe has been shown to be an effective method but with frequent side effects. To overcome the problem of adverse effects, a new approach using danazol was proposed, but the efficacy and acceptability of this treatment has not yet been put to the test in larger groups. In a 5-year period at the AIECS Family Planning Center in Milan, the authors treated 2448 women requesting postcoital contraceptives using Yuzpe's regimen and 2 danazol regimens (800 mg/1200 mg). The danazol treatment met with a greater measure of patient acceptability than did Yuzpe's regimen, due mainly to the smaller number of side effects. 9 pregnancies occurred in the EE-NG group (2.21%), 17 in the 800 mg group (1.71%), and 6 in the 1200 mg group (0.82%). This study shows a statistically significant efficacy against expected pregnancy rates, both with Yuzpe's regimen and with danazol. The 1200 mg danazol treatment seems to be more effective and can be considered a valid alternative to the EE-NG combination for hormonal postcoital contraception.
Authors:
G Zuliani; U F Colombo; R Molla
Related Documents :
12972838 - Common oral manifestations during pregnancy: a review.
3021108 - Spontaneous rupture of an hepatic adenoma in pregnancy with survival of mother and fetus.
12267108 - A multicenter randomized comparative investigation of ml cu250, tcu-220c and cu7 iuds.
15495018 - Immediate postabortal insertion of intrauterine devices.
9510058 - Effects of increasing gestation, cortisol and maternal undernutrition on hypothalamic n...
8145208 - Genetic basis of prolificacy in meishan pigs.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  37     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  1990 Dec 
Date Detail:
Created Date:  1990-12-12     Completed Date:  1990-12-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  253-60     Citation Subset:  IM; J    
Affiliation:
AIECS Family Planning Centre, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Contraceptives, Postcoital, Hormonal* / adverse effects
Danazol / administration & dosage*
Drug Administration Schedule
Drug Combinations
Ethinyl Estradiol / administration & dosage*
Female
Humans
Norgestrel / administration & dosage*
Pregnancy
Chemical
Reg. No./Substance:
0/Contraceptives, Postcoital, Hormonal; 0/Drug Combinations; 17230-88-5/Danazol; 57-63-6/Ethinyl Estradiol; 6533-00-2/Norgestrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The pin-hole cervical os; a small fertility problem.
Next Document:  Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer.